These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17906018)

  • 1. How relevant are ACOG and SGO guidelines for referral of adnexal mass?
    Dearking AC; Aletti GD; McGree ME; Weaver AL; Sommerfield MK; Cliby WA
    Obstet Gynecol; 2007 Oct; 110(4):841-8. PubMed ID: 17906018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of referral guidelines for women with pelvic masses.
    Im SS; Gordon AN; Buttin BM; Leath CA; Gostout BS; Shah C; Hatch KD; Wang J; Berman ML
    Obstet Gynecol; 2005 Jan; 105(1):35-41. PubMed ID: 15625139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of the modified ACOG/SGO referral criteria for adnexal mass within a limited-resource setting.
    Battarbee A; Strohl A; Zimmerman L; Patel A; Burtch R
    Int J Gynaecol Obstet; 2017 Jan; 136(1):53-57. PubMed ID: 28099697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical performance of a multivariate index assay for detecting early-stage ovarian cancer.
    Longoria TC; Ueland FR; Zhang Z; Chan DW; Smith A; Fung ET; Munroe DG; Bristow RE
    Am J Obstet Gynecol; 2014 Jan; 210(1):78.e1-9. PubMed ID: 24055582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for referral of the patient with an adnexal mass.
    Gostout BS; Brewer MA
    Clin Obstet Gynecol; 2006 Sep; 49(3):448-58. PubMed ID: 16885652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of women with apparent early ovarian cancer in the south-west region of England.
    Olaitan A; Murdoch J; Weeks J; James J; Howe K
    J Obstet Gynaecol; 2002 Jul; 22(4):394-8. PubMed ID: 12521463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancer.
    Baron AT; Cora EM; Lafky JM; Boardman CH; Buenafe MC; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):103-13. PubMed ID: 12582019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
    Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
    J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.
    Miller RW; Smith A; DeSimone CP; Seamon L; Goodrich S; Podzielinski I; Sokoll L; van Nagell JR; Zhang Z; Ueland FR
    Obstet Gynecol; 2011 Jun; 117(6):1298-1306. PubMed ID: 21555961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gynecologists' perspectives regarding ovarian cancer.
    Fitch MI; Gray RE; Covens A; Thomas G; Franssen E; DePetrillo D; Rosen B
    Cancer Prev Control; 1999 Feb; 3(1):68-76. PubMed ID: 10474755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of serum biomarkers for detection of early-stage ovarian cancer.
    Nosov V; Su F; Amneus M; Birrer M; Robins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2009 Jun; 200(6):639.e1-5. PubMed ID: 19285648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass.
    Bristow RE; Hodeib M; Smith A; Chan DW; Zhang Z; Fung ET; Tewari KS; Munroe DG; Ueland FR
    Am J Obstet Gynecol; 2013 Dec; 209(6):581.e1-8. PubMed ID: 23942039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
    Booth SJ; Turnbull LW; Poole DR; Richmond I
    BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls in the construction of cancer guidelines demonstrated by the analyses of colorectal referrals.
    Hodder RJ; Ballal M; Selvachandran SN; Cade D
    Ann R Coll Surg Engl; 2005 Nov; 87(6):419-26. PubMed ID: 16263008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Early detection and preoperative diagnosis of ovarian carcinoma].
    Kainz C
    Wien Med Wochenschr; 1996; 146(1-2):2-7. PubMed ID: 8835487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals.
    Tingulstad S; Hagen B; Skjeldestad FE; Halvorsen T; Nustad K; Onsrud M
    Obstet Gynecol; 1999 Mar; 93(3):448-52. PubMed ID: 10074998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs, effectiveness, and workload impact of management strategies for women with an adnexal mass.
    Havrilesky LJ; Dinan M; Sfakianos GP; Curtis LH; Barnett JC; Van Gorp T; Myers ER
    J Natl Cancer Inst; 2015 Jan; 107(1):322. PubMed ID: 25515232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Referral guidelines for colorectal cancer--do they work?
    Eccersley AJ; Wilson EM; Makris A; Novell JR
    Ann R Coll Surg Engl; 2003 Mar; 85(2):107-10. PubMed ID: 12648341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of gynecologic oncologists in the treatment of patients with a suspicious ovarian mass.
    Goff BA; Miller JW; Matthews B; Trivers KF; Andrilla CH; Lishner DM; Baldwin LM
    Obstet Gynecol; 2011 Oct; 118(4):854-62. PubMed ID: 21934449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary appendiceal cancer: gynecologic manifestations and treatment options.
    Dietrich CS; Desimone CP; Modesitt SC; Depriest PD; Ueland FR; Pavlik EJ; Kryscio R; Cibull M; Huh W; Partridge E; Numnum TM; Schilder J; Higgins RV; van Nagell JR
    Gynecol Oncol; 2007 Mar; 104(3):602-6. PubMed ID: 17055559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.